Eton Pharmaceuticals (ETON) Change in Account Payables (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Change in Account Payables data on file, last reported at -$3.3 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Account Payables fell 321.59% year-over-year to -$3.3 million; the trailing twelve-month figure through Dec 2025 stood at $6.8 million (up 193.7% YoY), and the FY2025 full-year result was $6.8 million, up 193.7% from the prior year.
• Change in Account Payables retreated to -$3.3 million in Q4 2025, from $2.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.3 million in Q2 2025 to a low of -$3.3 million in Q4 2025.
• A 5-year average of $430050.0 and a median of $11500.0 in 2022 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables plunged 1033.09% in 2021 and surged 5688.46% in 2025, its largest moves.
• Tracing ETON's Change in Account Payables over 5 years: stood at -$1.3 million in 2021, then jumped by 156.11% to $712000.0 in 2022, then tumbled by 85.25% to $105000.0 in 2023, then soared by 1311.43% to $1.5 million in 2024, then slumped by 321.59% to -$3.3 million in 2025.
• Business Quant data shows ETON's Change in Account Payables at -$3.3 million in Q4 2025, $2.1 million in Q3 2025, and $7.3 million in Q2 2025.